Fresubin 2 kcal Drink by Fresenius Kabi - high-calorie nutrition in a small bottle

Fresubin 2 kcal Drink sits chilled in the hospital fridge, a small 200 ml bottle that feels surprisingly heavy in the hand for its size. The vanilla aroma hits the nose even before the foil lid comes off. Dietitian Dr. Julia Meyer watches closely as a patient takes the first slow sip.

Compact calories for fragile patients

Fresubin 2 kcal Drink is an oral nutritional supplement from Fresenius Kabi designed to deliver 2 kcal per milliliter, meaning one 200 ml bottle provides about 400 kcal and at least 20 g of protein, depending on the flavor.

It targets adults with or at risk of malnutrition, including oncology, geriatric, and post-surgery patients who cannot cover their needs through normal meals alone. This high energy density allows clinicians to support intake even when appetite and swallowing capacity are limited.

Formulas, flavors and key nutrients

The Fresubin 2 kcal Drink range comes in several flavors, including vanilla, chocolate, cappuccino, strawberry and neutral, giving dietitians room to adapt to patient taste and tolerance. Each bottle is ready-to-drink and usually lactose-poor and gluten-free, depending on the exact variant.

According to Fresenius Kabi, a typical Fresubin 2 kcal Drink provides around 20 g of high-quality milk protein per 200 ml, alongside fat and carbohydrate sources optimized for medical nutrition, plus vitamins and minerals in a balanced profile. The official Fresubin 2 kcal product page by Fresenius Kabi describes the formulation and indication in detail and highlights its use in disease-related malnutrition.

Where Fresubin 2 kcal fits in the Kabi portfolio

Within Fresenius Kabi, Fresubin 2 kcal Drink belongs to the clinical nutrition segment that also includes tube feeds and parenteral nutrition. Fresenius Kabi positions itself as a specialist for clinical nutrition, IV drugs and medical devices, with Fresubin as one of its core brands.

In Fresenius presentations, management around CEO Michael Sen regularly points to Kabi’s nutrition portfolio as a stabilizing revenue pillar alongside injectables and biosimilars. Oral supplements like Fresubin 2 kcal Drink serve as an interface between hospital treatment and home care, extending revenue beyond the inpatient stay.

Pricing, reimbursement and availability

Fresubin 2 kcal Drink is categorized as a food for special medical purposes and is typically reimbursable on prescription in several European markets, including Germany, subject to national rules. In German pharmacy listings, a common retail reference price per 4-bottle pack sits in the mid single-digit euro range per bottle, depending on contract and channel.

Fresenius Kabi distributes Fresubin 2 kcal Drink broadly via hospitals, specialized medical retailers and pharmacies, with localized branding and flavor availability in regions such as Europe, Latin America and Asia. On the official Fresubin Germany site, the product is presented with dosage recommendations and safety notes, underscoring its status as a medically supervised nutrition rather than a general lifestyle drink.

Clinical context and evidence base

Clinical nutrition guidelines, for example from ESPEN, recommend high-energy oral nutritional supplements for patients at risk of malnutrition or with increased energy needs when normal food is not sufficient. Fresubin 2 kcal Drink is aligned with this approach by concentrating calories and protein into a small volume.

Studies on high-calorie oral supplements have shown improvements in weight maintenance and sometimes reduced complication rates in frail elderly and oncology patients when used consistently under professional supervision. While Fresenius Kabi highlights such general evidence in its medical communication, prescribing decisions remain with physicians and dietitians who tailor choice and dosing to individual patients.

Role in Fresenius SE & Co. KGaA’s business

For Fresenius SE & Co. KGaA, Fresubin 2 kcal Drink is a single SKU inside a much larger Fresubin family, but it contributes to a recurring, relatively resilient revenue flow in clinical nutrition. That steadiness can offset more cyclical or capital-intensive areas such as hospital operations historically consolidated in the group.

On Xetra, the Fresenius SE & Co. KGaA share trades in euros under ISIN DE0005785604, with the clinical nutrition activities of Fresenius Kabi, including Fresubin 2 kcal Drink, forming one of several operational streams that investors monitor for growth and margins.